GrindNshiP schreef op 31 jan 2017 om 17:05:
Curetis’ Global Installed Base Expanding to Over 150
- Completion of EMEA Direct Sales team build-out drives 46% growth in
system installations over the course of 2016
- Reported unaudited FY 2016 revenue and strong year-end cash position
Amsterdam, the Netherlands, and Holzgerlingen, Germany, January 31, 2017 - Curetis
N.V. (Euronext: CURE, the "Company" and, together with Curetis GmbH, "Curetis"), a
developer of next-level molecular diagnostic solutions, today announced the installation of its
milestone 150th Unyvero Analyzer worldwide.
Curetis has now grown its installed base of Unyvero Analyzers to 151 as of 31 January
2017. This compares with 103 Analyzers as of the end of 2015, 113 at mid-2016 and 121 as
of 30 September 2016.
“We are very pleased to reach this important installed base target, which represents 46%
growth in system installations over the course of 2016 and the first month of 2017,” said Dr.
Oliver Schacht, CEO of Curetis. “As expected, we have started to see significant momentum
in placement rates beginning in Q4, 2016, and continuing into early 2017 following the
completion of the build out of our EMEA direct sales team in Q3, 2016. Since then, our sales
pipeline has expanded dramatically, both in terms of number and quality of prospective
customers. We expect this pipeline growth to continue as we approach key inflection points
in strategic markets such as the U.S., where our application for 510(k) clearance is currently
under review by the FDA. Overall we are now well positioned to deliver further growth in
The acceleration in placements towards the end of 2016 and first month of 2017 was
predominantly driven by the completion of the build out of Curetis’ EMEA Direct Sales team,
which became fully staffed and operational in the third quarter of 2016 across all of Curetis’
direct selling markets in the region.
Since September 30, 2016, new Unyvero Analyzer installations were placed in Germany (4),
UK (9), France (8), and Switzerland (3) leading to a current installed base in the Company’s
direct selling markets of:
? Germany: 44
? UK: 16
? France: 16
? BeNeLux: 3
? Switzerland: 3
In addition, Curetis’ pipeline of prospects has doubled from about 100 active leads early in
2016 to about 200 active leads currently, across all direct selling markets. As well as seeing
growth in its direct selling markets, the Company recently signed new distribution
partnerships in Greece and Israel, expanding its global distributor network, from 10
distribution partnerships to 12 across 26 countries.